InVivo Therapeutics Holdings Corporation
Hedge Funds Holdings
Last updated:
InVivo Therapeutics Holdings Corporation‘s stocks are currently a part of 11 hedge funds’ portfolios, which represents 3.34% of the total amount of its stocks outstanding. This makes up a total of 51.30K shares of InVivo Therapeutics Holdings Corporation. Compared to the previous quarter, the number fell by -83.23% or -254.57K shares fewer. As for the holding position changes, 9.09% (1) of current hedge fund investors increased the number of shares held, 18.18% (2) of current holders sold a part of the shares held, and 18.18% (2) closed the holdings completely. 4 hedge funds are new holders of InVivo Therapeutics Holdings Corporation stock in Q1 2023, it is 36.36% of total holders.
Hedge funds holding InVivo Therapeutics Holdings (Q2 2018 – Q1 2023)
| Q2 2018 | 17 |
|---|---|
| Q3 2018 | 16 |
| Q4 2018 | 16 |
| Q1 2019 | 17 |
| Q2 2019 | 15 |
| Q3 2019 | 10 |
| Q4 2019 | 11 |
| Q1 2020 | 8 |
| Q2 2020 | 5 |
| Q3 2020 | 4 |
| Q4 2020 | 6 |
| Q1 2021 | 15 |
| Q2 2021 | 14 |
| Q3 2021 | 13 |
| Q4 2021 | 16 |
| Q1 2022 | 15 |
| Q2 2022 | 6 |
| Q3 2022 | 12 |
| Q4 2022 | 14 |
| Q1 2023 | 11 |
Hedge funds changes in InVivo Therapeutics Holdings positions (Q2 2018 – Q1 2023)
| Q2 2018 | 16 | 1 | 0 | 30 | -30 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 6 | 2 | 5 | -1 |
| Q4 2018 | 4 | 3 | 2 | 4 | 3 |
| Q1 2019 | 2 | 2 | 2 | 1 | 10 |
| Q2 2019 | 2 | 2 | 2 | 4 | 5 |
| Q3 2019 | 1 | 1 | 1 | 6 | 1 |
| Q4 2019 | 4 | 2 | 0 | 3 | 2 |
| Q1 2020 | 8 | 0 | 0 | 11 | -11 |
| Q2 2020 | 1 | 3 | 0 | 3 | -2 |
| Q3 2020 | 1 | 2 | 0 | 3 | -2 |
| Q4 2020 | 4 | 1 | 0 | 2 | -1 |
| Q1 2021 | 11 | 4 | 0 | 2 | -2 |
| Q2 2021 | 2 | 5 | 5 | 3 | -1 |
| Q3 2021 | 3 | 3 | 1 | 4 | 2 |
| Q4 2021 | 6 | 2 | 1 | 3 | 4 |
| Q1 2022 | 4 | 4 | 2 | 4 | 1 |
| Q2 2022 | 5 | 0 | 0 | 14 | -13 |
| Q3 2022 | 6 | 5 | 0 | 0 | 1 |
| Q4 2022 | 5 | 3 | 2 | 4 | 0 |
| Q1 2023 | 4 | 1 | 2 | 2 | 2 |
Hedge funds changes in InVivo Therapeutics Holdings stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 1,000 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of InVivo Therapeutics Holdings Corporation (NASDAQ:NVIV)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| CITADEL ADVISORS LLC Ken Griffin | 184K | 42.79K | 0.000% |
| BLACKROCK INC. Larry Fink | 149K | 34.71K | 0.000% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 119K | 27.72K | 0.000% |
| VANGUARD GROUP INC | 73K | 16.94K | 0.000% |
| TWO SIGMA INVESTMENTS, LP John Overdeck | 49K | 11.52K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 47K | 11.16K | 0.000% |
| TWO SIGMA ADVISERS, LP | 45K | 10.46K | 0.000% |
| UBS GROUP AG | 24K | 5.53K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 7K | 1.75K | 0.000% |
| MORGAN STANLEY | 6K | 1.46K | 0.000% |
| IFP ADVISORS, INC | 1K | 1 | 0.000% |
| IFP ADVISORS, INC | 1K | 1 | 0.000% |
| SUGARLOAF WEALTH MANAGEMENT, LLC | 1K | 1 | 0.000% |